Home -> Law Blog Directory -> Patent Law Blogs -> Daily Dose of IP
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Daily Dose of IPUSPTO to Host Deferred Patent Examination Roundtable
By Mark Reichel, Esq.
As a side note, the USPTO actually does have a procedure in place (as noted within the excerpt link below) to defer substantive examination for up to three years from the earliest filing date for which a benefit is claimed under Title 35 of the U.S. Code. Since November 29, 2000, which was also the effective date of the USPTO eighteen month publication rule, less than 200 applications have utilized this deferral procedure (provided under 37 C.F.R. § 1.103(d)).
Federal Register Excerpt (PDF): LINK
37 C.F.R. § 1.103(d): LINK
Full post as published by Daily Dose of IP on February 03, 2009 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment
Qualcomm Settles Patent Suit for $891 Million
The Princeton Review
$2.6 million settlement reached in patent infringement case.

USPTO News: USPTO Schedules Roundtable Discussion on Deferred Examination
U.S. Patent Office to Host Roundtable on Deferred Examination.
Deferred Examination: Does Putting Things Off Lesson Your Workload
USPTO considering deferred examination option for patent applications
Patently-O Bits and Bytes No. 44: Deferred Examination







